![Cong Xu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cong Xu
Private Equity Investor bij LAV Management Co., Ltd.
Actieve functies van Cong Xu
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
LAV Management Co., Ltd.
![]() LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Private Equity Investor | 01-01-2018 | - |
Loopbaan van Cong Xu
Eerdere bekende functies van Cong Xu
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
IMPACT Therapeutics, Inc.
![]() IMPACT Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology IMPACT Therapeutics, Inc. manufactures pharmaceutical products. The firm develops discovery and commercialization of novel therapeutics to treat cancer and other life-threatening diseases. The company was founded in 2009 and is headquartered in Nanjing, China. | President | 01-01-2018 | 01-12-2019 |
Opleiding van Cong Xu
University of British Columbia | Masters Business Admin |
Clemson University | Graduate Degree |
Statistieken
Internationaal
China | 3 |
Canada | 2 |
Verenigde Staten | 2 |
Operationeel
Private Equity Investor | 1 |
President | 1 |
Masters Business Admin | 1 |
Sectoraal
Consumer Services | 3 |
Finance | 2 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
LAV Management Co., Ltd.
![]() LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Finance |
IMPACT Therapeutics, Inc.
![]() IMPACT Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology IMPACT Therapeutics, Inc. manufactures pharmaceutical products. The firm develops discovery and commercialization of novel therapeutics to treat cancer and other life-threatening diseases. The company was founded in 2009 and is headquartered in Nanjing, China. | Health Technology |